To adress the unmet need to dispose of relevant tools to value the efficacy of treatments for red blood cell disorders, INNOVHEM has developed two important and unique innovations :a simple and accurate method to quantify fetal hemoglobin in each red blood cell and a specific new method to measure intravascular hemolysis. Together with several generic biological assays, INNOVHEM offers a comprehensive and innovative platform that supports the development of new treatments for red blod cell pathologies, from preclinical to phase IV evaluation.
| Website | https://www.innovhem.fr/ |
| Employees | 5 (4 on RocketReach) |
| Founded | 2019 |
| Phone | +33 1 43 39 07 28 |
| Technologies |
JavaScript
,
HTML
,
Twitter
+6 more
(view full list)
|
| Industry | Biotechnology Research |
| Keywords | Treatment Efficacy, Blood Cell Analysis, Blood Diagnostics, Hematology Diagnostics, Hematology Testing, Innovative Medical Solutions, Clinical Diagnostics, Medical Diagnostics, Medical Devices, Healthcare Technology |
| Competitors | BASF, Evonik, Clariant, Huntsman Corporation, Solvay, SABIC, Dow, Wacker Biotech US, Ashland, Ferro - Vibrantz +38 more (view full list) |
Looking for a particular INNOVHEM employee's phone or email?
INNOVHEM Questions
Marie Cambot is the Co-founder and CEO of INNOVHEM.
4 people are employed at INNOVHEM.
Top INNOVHEM Employees
-
41
-
Laura Matabishi-Bibi
R and D Engineer at INNOVHEM
Brétigny-sur-Orge, FR -
Laura Bencheikh
Chef de projet at INNOVHEM
Chevilly Larue, FR1
Related Companies
